These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1726202)

  • 21. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
    Phillips H; Van Hook CJ; Butler T; Todd WM
    Chest; 1993 Nov; 104(5):1387-92. PubMed ID: 8222793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
    Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
    Kees F; Wellenhofer M; Bröhl K; Grobecker H
    Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice].
    Hanke K; Blum SP
    Fortschr Med Orig; 2002; 120(1):21-8. PubMed ID: 14518354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
    Imaizumi T; Ishikawa H; Hashimoto I
    J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
    [No Abstract]   [Full Text] [Related]  

  • 29. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
    Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
    Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
    Ito K; Ito M
    J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
    [No Abstract]   [Full Text] [Related]  

  • 32. A review of the pharmacokinetics of cefpodoxime proxetil.
    Borin MT
    Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil].
    Vyhnánek F; Lochmann O
    Epidemiol Mikrobiol Imunol; 1996 May; 45(2):68-70. PubMed ID: 8756403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefpodoxime proxetil in upper respiratory tract infections.
    Bergogne-Berezin E
    Drugs; 1991; 42 Suppl 3():25-33. PubMed ID: 1726205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacoeconomic comparison of amoxicillin/clavulanate and cefpodoxime proxetil in the treatment of acute otitis media.
    Landholt TF; Kotschwar TR
    Clin Ther; 1994; 16(2):327-33; discussion 271-2. PubMed ID: 8062326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
    Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
    J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
    Portier H; Chavanet P; Gouyon JB; Guetat F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():79-85. PubMed ID: 2127268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs recently released in Belgium. Cefpodoxime proxetil--Fosinopril.
    Harvengt C
    Acta Clin Belg; 1993; 48(4):284-7. PubMed ID: 8212980
    [No Abstract]   [Full Text] [Related]  

  • 40. Cefpodoxime proxetil--a new oral cephalosporin.
    Med Lett Drugs Ther; 1992 Nov; 34(884):107-8. PubMed ID: 1435506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.